DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 163 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q3 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,607,552 | -12.7% | 598,078 | -3.4% | 0.02% | -15.4% |
| Q2 2023 | $8,714,760 | +662.8% | 618,946 | +737.0% | 0.03% | +550.0% |
| Q1 2023 | $1,142,541 | -34.0% | 73,951 | +45.2% | 0.00% | -50.0% |
| Q3 2021 | $1,730,000 | -71.6% | 50,926 | -69.3% | 0.01% | -70.4% |
| Q2 2021 | $6,081,000 | -46.2% | 166,100 | -8.6% | 0.03% | -54.2% |
| Q4 2019 | $11,308,000 | +5.4% | 181,680 | -42.5% | 0.06% | -10.6% |
| Q3 2019 | $10,728,000 | +132.9% | 316,101 | +54.7% | 0.07% | +175.0% |
| Q2 2019 | $4,606,000 | -26.9% | 204,274 | -31.9% | 0.02% | -22.6% |
| Q4 2018 | $6,297,000 | – | 300,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $69,030,000 | 15.95% |
| SV Health Investors, LLC | 449,951 | $25,679,000 | 12.37% |
| Sunesis Advisors, LLC | 96,299 | $5,496,000 | 4.45% |
| Redmile Group, LLC | 4,437,968 | $253,275,000 | 3.07% |
| Consonance Capital Management LP | 484,671 | $27,660,000 | 2.58% |
| SECTORAL ASSET MANAGEMENT INC | 488,842 | $27,898,000 | 1.97% |
| Opaleye Management Inc. | 222,000 | $12,670,000 | 1.66% |
| Eversept Partners, LP | 246,240 | $14,052,917 | 1.65% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 38,620 | $2,204,000 | 1.28% |
| Avoro Capital Advisors LLC | 1,300,000 | $74,191,000 | 1.28% |